banner

70 and Over Community

Older patients may face unique issues when dealing with a breast cancer diagnosis. Hear how older breast survivors personalized their care with tools like the Oncotype DX genomic test.

Take Charge of Your Health

Take Charge of Your Health

Share the Message

Share images on Instagram, Facebook, Twitter or Pinterest, and tag them with #NoMatterMyAge to help us get the word out.

Share Your Story

Know the Facts

Genomic testing rates in patients over 70 go down 3-fold compared to younger patients3

Age shouldn’t affect your chances of getting the right breast cancer treatment. Yet an analysis from the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry revealed that patients over 70 were far less likely to get a genomic test compared to patients 40-70 years of age.3 Talk to your doctor about your care, including whether or not a genomic test may help determine the best treatment plan for you – no matter your age.

Know the Facts

Age Shouldn’t Determine Whether a Patient Gets Standard of Care

Studies have found that older breast cancer patients are less likely to receive care that follows guideline recommendations.5 The Oncotype DX test helps patients* determine their risk of distant recurrence and whether chemotherapy is necessary in addition to hormone therapy. The test has been used by over a million patients, yet some breast cancer patients aren’t offered this important tool. Have a conversation with your doctor to learn how a genomic test can help you better understand and personalize your treatment options.

Patients with early stage, hormone receptor-positive, HER2-negative breast cancer

Know the Facts

Patients Deserve to Know if They Need Chemotherapy or Not

For some patients, chemotherapy can help reduce the risk of breast cancer coming back. It’s important to have all the information about your cancer when making a treatment decision. The Oncotype DX test has been used by over a million patients and helps them and their doctors understand whether chemotherapy is needed in addition to hormone therapy.1 If you want to know, ask your doctor for your genomic test result.

Know the Facts

Genomic testing rates in patients over 70 go down 3-fold compared to younger patients3

Age shouldn’t affect your chances of getting the right breast cancer treatment. Yet an analysis from the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) Registry revealed that patients over 70 were far less likely to get a genomic test compared to patients 40-70 years of age.3 Talk to your doctor about your care, including whether or not a genomic test may help determine the best treatment plan for you – no matter your age.

Age Shouldn’t Determine Whether a Patient Gets Standard of Care

Studies have found that older breast cancer patients are less likely to receive care that follows guideline recommendations.5 The Oncotype DX test helps patients* determine their risk of distant recurrence and whether chemotherapy is necessary in addition to hormone therapy. The test has been used by over a million patients, yet some breast cancer patients aren’t offered this important tool. Have a conversation with your doctor to learn how a genomic test can help you better understand and personalize your treatment options.

Patients with early stage, hormone receptor-positive, HER2-negative breast cancer

Patients Deserve to Know if They Need Chemotherapy or Not

For some patients, chemotherapy can help reduce the risk of breast cancer coming back. It’s important to have all the information about your cancer when making a treatment decision. The Oncotype DX test has been used by over a million patients and helps them and their doctors understand whether chemotherapy is needed in addition to hormone therapy.1 If you want to know, ask your doctor for your genomic test result.

Patient Resources

Helpful patient organizations for you or your loved one facing a breast cancer diagnosis

Additional Readings

Learn more about the age bias issues in genomic testing and treatments for breast cancer patients

If you have been diagnosed with early-stage invasive breast cancer, MyBreastCancerTreatment can help you overcome challenges of understanding your diagnosis by providing information and treatment options.